findmyKOL

Meggan Mackay, MD

Enriched profile

Professor and Co-Director, Clinical Trials Unit, Center for Autoimmune, Musculoskeletal and Hematopoietic Diseases · Feinstein Institutes for Medical Research (Northwell Health)

ORCIDNPI
Region🇺🇸 Manhasset, NY · Northeast · United StatesSpecialtyRheumatologyFocusSystemic Lupus Erythematosus Research+4
Active KOLfindmyKOL typefindmyKOL type: our influence ranking, shown when you reveal the full profileLatest publication2026Online presenceNone verifiedPayments2021–2022NIH funding2008–2026

Meggan Mackay is Professor and Co-Director, Clinical Trials Unit, Center for Autoimmune, Musculoskeletal and Hematopoietic Diseases at Feinstein Institutes for Medical Research (Northwell Health). OpenAlex indexes 165 publications with 8,182 citations (h-index 49); ClinicalTrials.gov lists 7 registered studies with this person as an investigator.

Data verified 14 Aug 2026

Overview

Updated 27 Aug 2026

Meggan Mackay, MD, is Professor and Co-Director, Clinical Trials Unit, Center for Autoimmune, Musculoskeletal and Hematopoietic Diseases at Feinstein Institutes for Medical Research (Northwell Health). The public record shows 165 publications with 8,182 citations (h-index 49), centered on Systemic Lupus Erythematosus Research, T-cell and B-cell Immunology, Rheumatoid Arthritis Research and Therapies. It also documents an investigator role on 7 registered clinical trials, industry payments reported by 3 companies, 4 NIH-funded awards (2008–2026).

  • Most recent indexed publication: 2026 · Arthritis care & research
  • Top research focus: Systemic Lupus Erythematosus Research
  • 7 registered trials on ClinicalTrials.gov
  • Open Payments reporting from 3 companies

Generated from the cited public record · current as of 27 Aug 2026. Every fact links its source below.

Indications focus

from trials led + research topics
Lupus (SLE)6 trialsST Elevation Myocardial Infarction6 trialsErythema6 trialsRheumatoid Arthritis2 trialsMultiple Sclerosis1 trialGlomerular Disease1 trialNephritis1 trialLupus Vasculitis, Central Nervous System1 trialScleroderma, Systemic1 trialMyositis1 trialDermatomyositis1 trialPemphigus1 trial

Research focus

OpenAlex concept fingerprint
Systemic Lupus Erythematosus ResearchT-cell and B-cell ImmunologyRheumatoid Arthritis Research and TherapiesMonoclonal and Polyclonal Antibodies ResearchMultiple Sclerosis Research Studies

Drugs & molecules

across trials, industry payments and publications
Benlystageneric · BelimumabClinical trialsIndustry payments1Publications1Lupkynisgeneric · VoclosporinClinical trialsIndustry payments2Publications

Works with

trial sponsors and companies reporting payments
National Institute of Allergy and Infectious Diseases (NIAID)Clinical trials3Industry paymentsNorthwell HealthClinical trials3Industry paymentsAurinia Pharma U.S., Inc.Clinical trialsIndustry payments2

Scholarship

indexed output and impact (OpenAlex)
View publications ↓
165publications

Distinct works indexed by OpenAlex, matched via ORCID; 6 in PubMed.

8,182citations

Total citations across indexed works.

49h-index

Hirsch index (OpenAlex). i10-index 80.

Clinical & industry

trials, payments and federal funding
7clinical trials

Investigator role on registered studies.

View trials
3companies · 2021–2022

Companies reporting payments to CMS. Facts, not judgments.

View payments
4NIH grants · 2008–2026

Federally funded research awards.

View funding

Contact

The practice address and phone this provider lists in the federal NPPES (CMS) registry.

Practice address

Telephone

Practice address and telephone from the federal NPPES registry.

Sign in to view contact details →

Clinical trials

Updated 27 Aug 2026

Listed as an investigator on 7 registered studies on ClinicalTrials.gov. The most recent:

4 more trial records behind the reveal.Reveal →

Industry payments

Updated 27 Aug 2026

3 companies reported payments to CMS in program years 2021–2022. These are public disclosures, not judgments. The latest:

Medicare prescribing footprint (2024)

The drugs this prescriber writes for Medicare patients, grouped by drug class and therapeutic area. Every percentage is a share of their total prescribing, so you can see what they prescribe most. These are proportions, not patient counts or dollar amounts. No condition is inferred: the claims record what was prescribed, never why.

  • Antiparasitic

    32.3%
    Antimalarial32.3%
    Hydroxychloroquine Sulfate100%
    Part D31 patients
  • Metabolism & gastrointestinal

    18.1%
    Corticosteroid13.6%
    Prednisone100%
    Part D20 patients
    Biguanide (metformin)2.3%
    Metformin Hcl100%
    Part D<11 patients
  • Cancer & immunology

    17.7%
    B Lymphocyte Stimulator-specific Inhibitor8.9%
    Benlysta100%
    Part D<11 patients
    Antirheumatic Agent6.2%
    Leflunomide100%
    Part D<11 patients
5 more therapeutic areas behind the reveal.Reveal →

Drug classes come from the WHO ATC and U.S. National Library of Medicine (RxClass) classifications; prescribing counts come from the CMS Medicare Part D Prescribers file. Each drug is counted once, under its primary class. Medicare fee-for-service only, so no Medicare Advantage, commercial, or pediatric prescribing is included. CMS publishes this data about 17 months after the fact.

NIH funding

Updated 27 Aug 2026

4 NIH research awards on record, funded 20082026 per NIH RePORTER. The latest:

Publications

Updated 27 Aug 2026

Their five most recent publications, matched to their ORCID record and linked to PubMed.

Network

Updated 27 Aug 2026

The people this person publishes with most, by number of co-authored papers. Names link to their own profile when we have one.

Online presence

Updated 27 Aug 2026

This person's own public accounts first, then places where others mention them. Two different things, listed separately.

Mentions by others

where others cite or feature them
  • Other

    lupusresearch.org/join-a-free-live-webcast-lupus-and-cognitive-health

    verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →lupusresearch.org
  • Other

    lupusresearch.org/scientific-discovery-from-lab-to-you/meggan-mackay

    verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →lupusresearch.org
  • Other

    slideshare.net/LupusNY/clinical-research-in-lupus-by-dr-meggan-mackay

    verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →slideshare.net
3 more mentions behind the reveal.Reveal →

We list an account only when the public record ties it to this person. verified means we've confirmed the match in more than one place; provisional means it looks right but we're still confirming.

Background & recognition

Updated 27 Aug 2026

Credentials, appointments and honors, newest first, each linked to the public source it came from.

Education

degrees and training on record
  • MD

    New York Medical College

    verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →feinstein.northwell.edu
  • MS

    Clinical Research Training Program, Albert Einstein College of Medicine

    verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →feinstein.northwell.edu

Editorial & leadership roles

journal and society appointments
  • Co-Director

    Clinical Trials Unit, Center for Autoimmune, Musculoskeletal and Hematopoietic Diseases, Feinstein Institutes

    verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →feinstein.northwell.edu
  • Lead investigator

    JBT-101 (lenabasum) trial for musculoskeletal pain in lupus, Feinstein Institutes

    verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →northwell.edu

Awards & honors

honors on the public record
1 more award behind the reveal.Reveal →

Secondary affiliations

appointments beyond the home institution
  • Associate Professor of Molecular Medicine and Medicine

    Donald and Barbara Zucker School of Medicine at Hofstra/Northwell

    verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →feinstein.northwell.edu
  • Former faculty

    Columbia University Medical Center (prior appointment)

    verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →feinstein.northwell.edu
  • Former faculty

    Albert Einstein College of Medicine, and Associate Director of Medicine, Jacobi Medical Center (prior appointment)

    verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →feinstein.northwell.edu

Media & interviews

press, podcasts and appearances

Every item links to where we found it. verified means we've confirmed it in more than one place; provisional means we found it and are still confirming.

Similar KOLs

Other experts from the same institution or the same specialty.